NUTM1 and nut midline carcinoma: Our research on ectopic expression systems in cell lines has dramatically enhanced our understanding of the molecular alterations that the NUTM1 fusion proteins generated, presented novel perspectives on the creation of new targeting medications, provided theoretical support for personalized treatment, and pointed out promising avenues for targeted therapies facilitate the progress in the treatment of NUT carcinoma.